NTBL Notable Labs: Utang jangka cendhak perusahaan

The price chart for Notable Labs, Ltd. (NTBL) illustrates the price action of an asset whose revenue is based on precision therapy selection via drug testing on a patient's live cells. The AI-driven PPND automated system independently analyzes blood tests to accelerate drug screening, with the metric standing at 0.00. High business resilience is ensured by prognostic patents and the ownership of rare databases.

NTBL Silihan lan utang jangka cendhak perusahaan Notable Labs Ltd (21.02.2024 - 02.11.2024)

The slow implementation of the Notable Labs, Ltd. (NTBL) platform in clinics and uncertainty regarding insurance reimbursements create liquidity risks, directly impacting the volume of short-term borrowings. An analysis of the company's current liabilities allows for the differentiation of speculative growth from a genuine recovery in solvency, where a stabilizing debt trajectory confirms a reduction in capital risks, while an excess of debt signals a crisis in operational efficiency.

Perusahaan pesaing

BeiGene - Utang jangka cendhak perusahaan|Halozyme Therapeutics, Inc. (HALO) - Kewajiban jangka cendhak perusahaan|RVMD: Utang jangka cendhak perusahaan|Utang jangka cendhak Ascentage Pharma Corp (AAPG)|Utang jangka cendhak perusahaan CG Oncology, Inc.|URGN: Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ERAS (Erasca Corp)|DCTH - Kewajiban jangka cendhak perusahaan|YMAB: Kewajiban jangka cendhak perusahaan|AURA - Utang jangka cendhak perusahaan|candeltx.com (CADL) - Utang jangka cendhak perusahaan|Accuray Inc - Silihan lan utang jangka cendhak perusahaan|SLS (SELLAS Life Sciences Group, Inc.) - Utang jangka cendhak perusahaan|Utang jangka cendhak Actuate Therapeutics Inc ACTU|Utang jangka cendhak perusahaan Citius Oncology, Inc. (CTOR)|tuhurabio.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Utang jangka cendhak|WHWK: Kewajiban jangka cendhak perusahaan|TScan Therapeutics - Gedhene kewajiban jangka cendhak|CSBR: Utang jangka cendhak perusahaan|XBiotech (XBIT) - Utang jangka cendhak perusahaan|CVM (CEL-SCI Corp.) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan OSTX|Utang jangka cendhak perusahaan Radiopharm Theranostics (RADX)|Utang jangka cendhak perusahaan ARTV (artivabio.com)|Utang jangka cendhak perusahaan ANL (Adlai Nortye)|verupharma.com (VERU) - Utang jangka cendhak|TPST: Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan XLO (Xilio Therapeutics, Inc.)|renovarobio.com (RENB) - Utang jangka cendhak perusahaan|MURA (Mural Oncology) - Utang jangka cendhak perusahaan|KAPA (Kairos Pharma Limited) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan OnKure|Utang jangka cendhak perusahaan GDTC|Utang jangka cendhak perusahaan CRIS (curis.com)|Utang jangka cendhak perusahaan Apollomics APLM|Gunggunge utang jangka cendhak Tharimmune Corporation (THAR)|ADVB: Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan GNPX (genprex.com)|calidibio.com (CLDI) - Utang jangka cendhak perusahaan|SBFM (sunshinebiopharma.com) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan XBIO|SLRX (Salarius Pharma) - Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan PPBT|aoncology.com - Tanggungan utang jangka cendhak perusahaan|BeiGene - Kewajiban jangka cendhak perusahaan|Gunggunge utang jangka cendhak Checkpoint Therapeutics Inc. (CKPT)|ELEV - Utang jangka cendhak perusahaan|ICAD (iCAD, Inc.) - Tanggungan utang jangka cendhak perusahaan|IKNA (ikenaoncology.com) - Kewajiban jangka cendhak perusahaan|VIRX: Gedhene kewajiban jangka cendhak|MOR (MorphoSys) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan NAYA|Utang jangka cendhak perusahaan Ascentage Pharma Group Ltd (AAPGV)